Racially classified social group tobacco-related health disparities: What is the role of genetics?

Addiction

Volumn 102, Issue SUPPL. 2, 2007, Pages 58-64

  Fernander, Anita F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Disparities; Genes; Race; Tobacco

Indexed keywords

CYTOCHROME P450 2A6; NICOTINE;

CONCEPTUAL FRAMEWORK; GENETIC DIFFERENCE; GENETIC VARIABILITY; HEALTH CARE; HUMAN; MORBIDITY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PHARMACOGENETICS; PSYCHOLOGIC ASSESSMENT; RACE; REVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE;

ETHNIC GROUPS; HEALTH STATUS; HUMANS; PHARMACOGENETICS; TOBACCO USE DISORDER;

EID: 34548573653     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01955.x     Document Type: Review

References (88)

1. King G. The 'Race' concept in smoking: a review of the research on African Americans. Soc Sci Med 1997 45 : 1075 87.
2. USDHHS. Tobacco Use Among U.S. Racial/Ethnic Minority Groups-African Americans American Indians, Alaskan Natives Asian Americans, Pacific Islanders, Hispanics: A Report of the Surgeon General. Atlanta, GA : US Department of Health and Human Services, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 1998.
3. Fagan P., Moolcham E. T., Lawrence D., Fernander A., Ponder P. L. Identifying health disparities across the tobacco continuum. Addiction 2007 102 (Suppl. 2 5 28.
4. USDHHS. Healthy People 2010: Understanding and Improving Health, 2nd edn. Washington, DC : U.S. Government Printing Office 2000.
5. Hall W., Madden P., Lynskey M. The genetics of tobacco use: methods, findings and policy implications. Tob Control 2002 11 : 119 24.
6. Lerman C., Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 2003 118B : 48 54.
7. Heath A. C., Kirk K. M., Meyer J. M., Martin N. G. Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behav Genet 1999 29 : 395 407.
8. Lerman C., Audrain J., Main D., Boyd N. R., Caporaso N. E., Bowman E. D. et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999 18 : 14 20.
9. Sullivan P. F., Kendler K. S. The genetic epidemiology of smoking. Nicotine Tob Res 1999 1 : S51 7.
10. Xu C., Goodz S., Sellers E. M., Tyndale R. F. CYP2A6 genetic variation and potential consequences. Adv Drug Deliv Rev 2002 54 : 1245 56.
11. Collins F. S., Green E. D., Guttmacher A. E., Guyer M. S. A vision for the future of genomics research. Nature 2003 422 : 835 47.
12. Shields A., Fortun M., Hammonds E. M., King P. A., Lerman C., Rapp R. et al. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am Psychol 2005 60 : 77 103.
13. Burchard E. G., Ziv E., Coyle N., Gomez S. L., Tang H., Karter A. J. et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003 348 : 1170 5.
14. Fullilove M. T. Comment: abandoning 'race' as a variable in public health research - an idea whose time has come. Am J Public Health 1998 88 : 1297 8.
15. Risch N., Burchard E., Ziv E., Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol 2002 3 : 1 12.
16. Rivara F. P., Finberg L. Use of the terms race and ethnicity. Arch Pediatr Adolesc Med 2001 155 : 119.
17. Schwartz R. Racial profiling in medical research. N Engl J Med 2001 344 : 1392 3.
18. Lee S. S. Racializing drug design: implications of pharmacogenomics for health disparities. Am J Public Health 2005 95 : 2133 8.
19. Lopez I. H. White by Law. New York : New York University Press 1996.
20. Mays V. M., Ponce N. A., Washington D. L., Cochran S. D. Classification of race and ethnicity: implications for public health. Annu Rev Public Health 2003 24 : 83 110.
21. Nobles M. History counts: a comparative analysis of racial/color categorization in US and Brazilian censuses. Am J Public Health 2000 90 : 1738 45.
22. Smedley A., Smedley B. D. Race as biology is fiction, racism as a social problem is real: anthropological and historical perspectives on the social construction of race. Am Psychol 2005 60 : 16 26.
23. Snowden F. M. Before Color Prejudice: The Ancient View of Blacks. Cambridge, MA : Harvard University Press 1983.
24. Cooper R. A note on the biological concept of race and its application in epidemiologic research. Am Heart J 1984 108 : 715 23.
25. Jordan W. White Over Black: American Attitudes Toward the Negro, 1550-1812. Chapel Hill : The University of North Carolina Press 1995.
26. Allen T. W. The Invention of the White Race, Vol. 1. London and New York : Verso 1994.
27. Allen T. W. The Invention of the White Race, Vol. 2. London and New York : Verso 1997.
28. Smedley A. Race in North America: Origin and Evolution of a Worldview, 2nd edn. Boulder, CO : Westview Press 1999.
29. Stocking G. The turn-of-the-century concept of race. Modernism/Modernity 1994 1 : 4 16.
30. Harris M., Consorte J. G., Lang J., Byrne B. Who are the Whites? Imposed census categories and the racial demography of Brazil. Soc Forces 1993 72 : 451 62.
31. Jacobson M. F. Whiteness of a Different Color: European Immigrants and the Alchemy of Race. Cambridge, MA : Harvard University Press 1998.
32. Fredrickson G. M. The Arrogance of Race. Middletown, CT : Wesleyan University Press 1998.
33. Fredrickson G. M. Racism: A Short History. Princeton, NJ : Princeton University Press 2002.
34. Morgan E. S. American Slavery, American Freedom. New York : Norton 1975.
35. Krieger N., Bassett M. The health of black folk: disease,class, and ideology. Mon Rev 1986 8 : 74 85.
36. Byrd W. M. Race, biology, and health care: reassessing a relationship. J Health Care Poor Underserved 1990 1 : 278 96.
37. Bonham V. L., Warshauer-Baker E., Collins F. S. Race and ethnicity in the genome era. Am Psychol 2005 60 : 9 15.
38. Ossorio P., Duster T. Race and genetics: controversies in biomedical, behavioral, and forensic sciences. Am Psychol 2005 60 : 115 28.
39. Cooper R. S., Kaufman J. S., Ward R. Race and genomics. N Engl J Med 2003 348 : 1166 70.
40. Krieger N. Stormy weather: race, gene expression, and the science of health disparities. Am J Public Health 2005 95 : 2155 60.
41. Lee S. S. Race, distributive justice and the promise of pharamacogenomics: ethical considerations. Am J Pharmacogenomics 2003 3 : 285 92.
42. Lee S. S., Mountain J., Koenig B. A. The meanings of 'race' in the new genomics: implications for health disparities research. Yale J Health Policy Law Ethics 2001 1 : 33 75.
43. Sankar P. Genetic privacy. Annu Rev Med 2003 54 : 393 407.
44. Lerman C., Caporaso N. E., Bush A., Zheng Y., Audrain J., Main D., Shields P. Tryptophan hydroxylase gene variant and smoking behavior. Am J Med Genet B Neuropsychiatr Genet 2001 105 : 518 20.
45. Audrain-McGovern J., Lerman C., Wileyto E. P., Rodriguez D., Shields P. G. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 2004 161 : 1224 30.
46. Lerman C., Caporaso N. E., Audrain J., Main D., Bowman E. D., Lockshin B. et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999 18 : 14 20.
47. Lerman C., Caporaso N. E., Audrain J., Main D., Boyd N. R., Shields P. G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol Psychiatry 2000 5 : 189 92.
48. Sabol S. Z., Nelson M. L., Fisher C., Gunzerath L., Brody C. L., Hu S. et al. A genetic association for cigarette smoking behavior. Health Psychol 1999 18 : 7 13.
49. Shields P. G., Lerman C., Audrain J., Bowman E. D., Main D., Boyd N. R. et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 1998 7 : 453 8.
50. Spitz M. R., Shi H., Yang F., Hudmon K. S., Jiang H., Chamberlain R. M. et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998 90 : 358 63.
51. Ahijevych K. Nicotine metabolism variability and nicotine addiction. Nicotine Tob Res 1999 1 : S59 62.
52. Caporaso N. E., Lerman C., Audrain J., Boyd N. R., Main D., Issaq H. J. et al. Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiol Biomarkers Prev 2001 10 : 261 3.
53. David S. P., Niaura R., Papandonatos G. D., Shadel W. G., Burkholder G. J., Britt D. M. et al. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res 2003 5 : 935 42.
54. Lerman C., Jepson C., Wileyto E. P., Epstein L. H., Rukstalis M., Patterson F. et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006 31 : 231 42.
55. Yudkin P., Munafo M., Hey K., Roberts S., Welch S., Johnstone E. et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 2004 328 : 989 90.
56. London S. J., Smart J., Daly A. K. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer 2000 28 : 147 55.
57. Taioli E., Crofts F., Trachman J., Demopoulos R., Toniolo P., Garte S. J. A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 1995 55 : 472 3.
58. Park J. Y., Muscat J. E., Kaur T., Schantz S. P., Stern J. C., Richie J. P. et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 2000 10 : 123 31.
59. Schoedel K. A., Hoffmann E. B., Rao Y., Sellers E. M., Tyndale R. F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004 14 : 615 26.
60. Yu M. C., Ross R. K., Chan K. K., Henderson B. E., Skipper P. L., Tannenbaum S. R. et al. Glutathione s-transferase m1 genotype affects aminobiphenyl-hemoglobin adduct levels in White, Black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995 4 : 861 4.
61. Ahijevych K., Gillespie J. Nicotine dependence and smoking topography among Black and White women. Res Nurs Heath 1997 20 : 505 14.
62. Ahijevych K., Gillespie J., Demirci M., Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in Black and White women. Pharmacol Biochem Behav 1996 53 : 355 60.
63. Ahijevych K., Parsley L. A. Smoke constituent exposure and stage of change in Black and White women cigarette smokers. Addict Behav 1999 24 : 115 20.
64. Ahijevych K., Tyndale R. F., Dhatt R. K., Weed H. G., Browning K. K. Factors influencing continine half-life during smoking abstinence in African American and Caucasian women. Nicotine Tob Res 2002 4 : 423 31.
65. Wagenknecht L. E., Cutter G. R., Haley N. J., Sidney S., Manolio T. A., Hughes G. H. et al. Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (young) adults study. Am J Public Health 1990 80 : 1053 6.
66. Benowitz N. L., Perez-Stable E. J., Fong I., Modin G., Herrera B., Jacob P. Ethnic differences in N-glucuronidation and nicotine and cotinine. J Pharmacol Exp Ther 1999 291 : 1196 203.
67. Moolchan E. T., Franken F. H., Jaszyna-Gasior M. Adolescent nicotine metabolism: ethnoracial differences among dependent smokers. Ethn Dis 2006 16 : 239 43.
68. Oscarson M., Gullsten H., Rautio A., Bernal M. L., Sinues B., Dahl M. et al. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. Fed Eur Biochem Soc 1998 438 : 201 5.
69. Oscarson M., McLellan R. A., Gullsten H., Agundez J., Benitez J., Rautio A. et al. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. Fed Eur Biochem Soc 1999 460 : 321 7.
70. Risch N. Dissecting racial and ethnic differences. N Engl J Med 2006 354 : 408 11.
71. Rosenberg N. A., Pritchard J. K., Weber J. L., Cann H. M., Kidd K. K., Zhivotovsky L. A. et al. Genetic structure of human populations. Science 2002 298 : 2381 5.
72. Tang H., Quertermous T., Rodriguez B., Kardia S. L. R., Zhu X., Brown A. et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005 76 : 268 75.
73. Berrettini W. H., Lerman C. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am J Psychiatry 2005 162 : 1441 51.
74. Lerman C., Shields P. G., Wileyto E. P., Audrain J., Pinto A., Hawk L. et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002 12 : 627 34.
75. Lerman C., Wileyto E. P., Audrain J., Pinto A., Kucharski S., Niaura R. et al. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol 2003 22 : 541 8.
76. Lerman C., Wileyto E. P., Patterson F., Rukstalis M., Audrain-McGovern J., Restine S. et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. J Pharmacogenomics 2004 4 : 184 92.
77. Lerman C., Patterson F., Berrettini W. Treating tobacco dependence: state of the science and new directions. J Clin Oncol 2005 23 : 311 23.
78. United States Department of Energy Office of Science. Pharmacogenomics. Human Genome Project Information Web site. Available at: http://www/prm;/gpv/ sci/techresources/Human_Genome/medicine/pharma.shtml (accessed 10 October 2006).
79. March R., Cheeseman K., Doherty M. Pharmacogenetics-legal, ethical and regulatory considerations. Pharmacogenomics 2001 2 : 317 27.
80. Veenstra D. L., Higashi M. K., Phillips K. A. Assessing the cost-effectiveness of pharmacogenomics. AAPS Pharmsci 2000 2 : E29.
81. Foster M. W., Sharp R. R. Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity. Genome Res 2002 12 : 844 50.
82. Foster M. W., Sharp R. R., Mulvihill J. J. Pharmacogenetics, race, and ethnicity: social identities and individualized medical care. Ther Drug Monit 2001 23 : 232 8.
83. Rothstein M. A., Epps P. G. Pharmacogenomics and the relevance of race. Pharmacogenomics J 2001 1 : 104 8.
84. Jones C. P. Invited commentary: 'race', racism, and the practice of epidemiology. Am J Epidemiol 2001 154 : 299 304.
85. Stevens J., (2003). Racial meanings and scientific methods: changing policies for NIH-sponsored publications reporting human variation. J Health Polit Policy Law 2003 28 : 1033 87.
86. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005 437 : 1299 320.
87. Fernander A., Shavers V., Hammons G. A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups. Addiction 2007 102 (Suppl. 2 58 64.
88. Moolchan E., Fagan P., Fernander A., Velicer W. F., Hayward M. D., King G. et al. Addressing tobacco-related health disparities. Addiction 2007 102 (Suppl. 2 30 42.